+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use and the risk of colorectal cancer: a population-based case-control study



Statin use and the risk of colorectal cancer: a population-based case-control study



World Journal of Gastroenterology 17(47): 5197-5202



To investigate whether the use of statins is associated with colorectal cancer risk. We conducted a population-based case-control study in Taiwan. Data were retrospectively collected from the Taiwan National Health Insurance Research Database. Cases consisted of all patients who were aged 50 years and older and had a first-time diagnosis of colorectal cancer between the period 2005 and 2008. The controls were matched to cases by age, sex, and index date. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multiple logistic regression. We examined 1156 colorectal cancer cases and 4624 controls. The unadjusted ORs for any statin prescription was 1.10 (95% CI = 0.94-1.30) and the adjusted OR was 1.09 (95% CI = 0.91-1.30). When statin use was categorized by cumulative dose, the adjusted ORs were 0.99 (95% CI = 0.78-1.27) for the group with cumulative statin use below 105 defined daily doses (DDDs); 1.07 (95% CI = 0.78-1.49) for the group with cumulative statin use between 106 and 298.66 DDDs; and 1.30 (95% CI = 0.96-1.75) for the group with cumulative statin use of 298.66 DDDs or more compared with nonusers. This study does not provide support for a protective effect of statins against colorectal cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911455

Download citation: RISBibTeXText

PMID: 22215945

DOI: 10.3748/wjg.v17.i47.5197


Related references

Colorectal Screening Is Associated with Reduced Colorectal Cancer Risk: A Case: Control Study within the Population-Based Ontario Familial Colorectal Cancer Registry. Cancer Causes & Control 16(7): 865-875, 2005

Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes and Control 16(7): 865-875, 2005

Statin use and the risk of breast cancer: a population-based case-control study. Expert Opinion on Drug Safety 13(3): 287-293, 2014

Statin use and the risk of bladder cancer: a population-based case-control study. Expert Opinion on Drug Safety 11(5): 733-738, 2013

Statin use and the risk of pancreatic cancer: a population-based case-control study. Pancreas 40(5): 669-672, 2011

Statin use and the risk of esophageal cancer: a population-based case-control study. Expert Opinion on Drug Safety 12(3): 293-298, 2013

Statin use and the risk of kidney cancer: a population-based case-control study. Expert Opinion on Drug Safety 11(4): 543-549, 2012

Statin use and the risk of female lung cancer: a population-based case-control study. Lung Cancer 75(3): 275-279, 2012

Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010. Cancer Epidemiology 38(1): 42-47, 2014

Beta blocker use and colorectal cancer risk: population-based case-control study. Cancer 118(16): 3911-3919, 2012

Relationship between XPD Lys 751 Gln polymorphism and colorectal cancer risk: a case-control study in a population-based study. Gastroenterology and Hepatology From Bed to Bench 6(1): 18-24, 2013

Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study. Cancer 118(5): 1236-1243, 2012

Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case-control study. Internal and Emergency Medicine 7(5): 431-438, 2013

Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 133(3): 755-760, 2007

Dietary patterns and colorectal cancer risk in Zimbabwe: A population based case-control study. Cancer Epidemiology 57: 33-38, 2018